Cerebrovascular Diseases
Original Paper
Dynamic Susceptibility Contrast Perfusion MRI Identifies Persistent Vessel Pathology in Acute Pontine StrokeFörster A. · Ottomeyer C. · Wolf M.E. · Kern R. · Griebe M. · Gass A. · Hennerici M.G. · Szabo K.Department of Neurology, Universitätsklinikum Mannheim, University of Heidelberg, Mannheim, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: October 05, 2009
Accepted: November 30, 2009
Published online: February 19, 2010
Issue release date: March 2010
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 2
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Abstract
Background: In large territorial stroke of the anterior and the posterior circulation, the extent of affected tissue can be characterized by the demonstration of vessel occlusion on MR angiography (MRA), while the extent of hypoperfusion can be shown on dynamic susceptibility contrast perfusion-weighted MRI (PWI). The ability of MRA and conventional MRI sequences to demonstrate branches of the basilar artery (BA) is very limited. This study analyzes the value of the combined use of diffusion-weighted MRI (DWI), MRA and PWI in acute pontine stroke. Methods: A series of 24 consecutive patients with acute pontine stroke received an extensive MRI stroke workup including DWI, PWI and MRA. Results: In 11/24 patients visual analysis of PWI demonstrated persisting hypoperfusion, and in 1/24 patients indication of hyperperfusion was found. Vessel abnormalities were seen in 19/24 patients (15/24 hypoplastic vertebral artery, 9/24 stenosis or occlusion of the BA, 1/20 ectatic BA). Persistent pontine hypoperfusion was more frequently associated with BA pathology (9/11 vs. 1/13, p = 0.001), large-vessel disease (8/11 vs. 1/13; p = 0.001) and a more pronounced clinical deficit (NIHSS score on day 1: 7 vs. 3, p = 0.01). Conclusions: In pontine ischemia areas of hypoperfusion can be identified due to the strong contrast induced by ischemia on PWI and can be easily related to DWI lesion size. This is of use particularly as small vessels are frequently missed by MRA and occlusion of the BA can be better characterized with the help of PWI.
© 2010 S. Karger AG, Basel
Related Articles:
References
- Kataoka S, Hori A, Shirakawa T, Hirose G: Paramedian pontine infarction: neurological/topographical correlation. Stroke 1997;28:809–815.
- Bassetti C, Bogousslavsky J, Barth A, Regli F: Isolated infarcts of the pons. Neurology 1996;46:165–175.
- Kim JS, Lee JH, Im JH, Lee MC: Syndromes of pontine base infarction: a clinical-radiological correlation study. Stroke 1995;26:950–955.
- Burger KM, Tuhrim S, Naidich TP: Brainstem vascular stroke anatomy. Neuroimaging Clin N Am 2005;15:297–324.
- Tatu L, Moulin T, Bogousslavsky J, Duvernoy H: Arterial territories of human brain: brainstem and cerebellum. Neurology 1996;47:1125–1135.
- Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009;27:502–508.
- Kumral E, Bayulkem G, Evyapan D: Clinical spectrum of pontine infarction: clinical-MRI correlations. J Neurol 2002;249:1659–1670.
- Vemmos KN, Spengos K, Tsivgoulis G, Manios E, Zis V, Vassilopoulos D: Aetiopathogenesis and long-term outcome of isolated pontine infarcts. J Neurol 2005;252:212–217.
- Kwon HM, Kim JH, Lim JS, Park JH, Lee SH, Lee YS: Basilar artery dolichoectasia is associated with paramedian pontine infarction. Cerebrovasc Dis 2009;27:114–118.
- Gerraty RP, Parsons MW, Barber PA, Darby DG, Desmond PM, Tress BM, et al: Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke 2002;33:2019–2024.
- Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, et al: Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007;38:3158–3164.
- Butcher K, Parsons M, Allport L, Lee SB, Barber PA, Tress B, et al: Rapid assessment of perfusion-diffusion mismatch. Stroke 2008;39:75–81.
- Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, et al: The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 2008;39:2491–2496.
- Fazekas F, Niederkorn K, Ebner F, Diez-Tejedor E: Relevance of neuroimaging in the evaluation of cerebral ischemia. Cerebrovasc Dis 2009;27(suppl 1):1–8.
- Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, et al: Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke: a preliminary report. Cerebrovasc Dis 2008;25:572–579.
- Kane I, Sandercock P, Wardlaw J: Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485–491.
- Sobesky J, Zaro WO, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, et al: Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005;36:980–985.
- Ostrem JL, Saver JL, Alger JR, Starkman S, Leary MC, Duckwiler G, et al: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004;35:e30–e34.
- Kohrmann M, Sauer R, Huttner HB, Engelhorn T, Doerfler A, Schellinger PD: MRI mismatch-based intravenous thrombolysis for isolated cerebellar infarction. Stroke 2009;40:1897–1899.
- Kim SJ, Ryoo S, Bang OY, Chung CS, Lee KH, Kim GM: Perfusion-weighted MRI as a predictor of clinical outcomes following medullary infarctions. Cerebrovasc Dis 2010;29: 382–388.
- Fitzek S, Fitzek C, Urban PP, Marx J, Hopf HC, Stoeter P: Time course of lesion development in patients with acute brain stem infarction and correlation with NIHSS score. Eur J Radiol 2001;39:180–185.
- Shimosegawa E, Hatazawa J, Inugami A, Fujita H, Ogawa T, Aizawa Y, et al: Cerebral infarction within six hours of onset: prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med 1994;35:1097–1103.
- Sakoh M, Rohl L, Gyldensted C, Gjedde A, Ostergaard L: Cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking after acute stroke in pigs: comparison with [15O]H2O positron emission tomography. Stroke 2000;31:1958–1964.
- Rohl L, Ostergaard L, Simonsen CZ, Vestergaard-Poulsen P, Andersen G, Sakoh M, et al: Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001;32:1140–1146.
Article / Publication Details
Received: October 05, 2009
Accepted: November 30, 2009
Published online: February 19, 2010
Issue release date: March 2010
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 2
ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)
For additional information: https://www.karger.com/CED
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
